Precision oncology firm Repare Therapeutics locks in funding

Montreal and Boston-based Repare Therapeutics Inc, a precision oncology company, has raised US$15 million in funding.

29 May 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles